Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease.

Huang JT, Chaudhuri R, Albarbarawi O, Barton A, Grierson C, Rauchhaus P, Weir CJ, Messow M, Stevens N, McSharry C, Feuerstein G, Mukhopadhyay S, Brady J, Palmer CN, Miller D, Thomson NC.

Thorax. 2012 Jun;67(6):502-8. doi: 10.1136/thoraxjnl-2011-200279. Epub 2012 Jan 16.

2.

Total desmosines in plasma and urine correlate with lung function.

Lindberg CA, Engström G, de Verdier MG, Nihlén U, Anderson M, Forsman-Semb K, Svartengren M.

Eur Respir J. 2012 Apr;39(4):839-45. doi: 10.1183/09031936.00064611. Epub 2011 Sep 29.

3.

Quantitation of desmosine and isodesmosine in urine, plasma, and sputum by LC-MS/MS as biomarkers for elastin degradation.

Ma S, Turino GM, Lin YY.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Jul 1;879(21):1893-8. doi: 10.1016/j.jchromb.2011.05.011. Epub 2011 May 13.

PMID:
21621489
4.

MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients.

Viglio S, Iadarola P, Lupi A, Trisolini R, Tinelli C, Balbi B, Grassi V, Worlitzsch D, Döring G, Meloni F, Meyer KC, Dowson L, Hill SL, Stockley RA, Luisetti M.

Eur Respir J. 2000 Jun;15(6):1039-45.

5.

Urinary desmosine excretion in acute exacerbations of COPD: a preliminary report.

Fiorenza D, Viglio S, Lupi A, Baccheschi J, Tinelli C, Trisolini R, Iadarola R, Luisetti M, Snider GL.

Respir Med. 2002 Feb;96(2):110-4.

PMID:
11860167
6.

Quantification of free and total desmosine and isodesmosine in human urine by liquid chromatography tandem mass spectrometry: a comparison of the surrogate-analyte and the surrogate-matrix approach for quantitation.

Ongay S, Hendriks G, Hermans J, van den Berge M, ten Hacken NH, van de Merbel NC, Bischoff R.

J Chromatogr A. 2014 Jan 24;1326:13-9. doi: 10.1016/j.chroma.2013.12.035. Epub 2013 Dec 18.

PMID:
24380655
7.

Desmosine as a biomarker of elastin degradation in COPD: current status and future directions.

Luisetti M, Ma S, Iadarola P, Stone PJ, Viglio S, Casado B, Lin YY, Snider GL, Turino GM.

Eur Respir J. 2008 Nov;32(5):1146-57. doi: 10.1183/09031936.00174807.

8.

Determination of free desmosine and isodesmosine as urinary biomarkers of lung disorder using ultra performance liquid chromatography-ion mobility-mass spectrometry.

Devenport NA, Reynolds JC, Parkash V, Cook J, Weston DJ, Creaser CS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Dec 15;879(32):3797-801. doi: 10.1016/j.jchromb.2011.10.016. Epub 2011 Oct 22.

PMID:
22088351
9.

Urinary desmosine excretion is inversely correlated with the extent of emphysema in patients with chronic obstructive pulmonary disease.

Cocci F, Miniati M, Monti S, Cavarra E, Gambelli F, Battolla L, Lucattelli M, Lungarella G.

Int J Biochem Cell Biol. 2002 Jun;34(6):594-604.

PMID:
11943590
10.

Measurement of urinary total desmosine and isodesmosine using isotope-dilution liquid chromatography-tandem mass spectrometry.

Albarbarawi O, Barton A, Lin Z, Takahashi E, Buddharaju A, Brady J, Miller D, Palmer CN, Huang JT.

Anal Chem. 2010 May 1;82(9):3745-50. doi: 10.1021/ac100152f.

PMID:
20361748
11.

Long-term variability of desmosine/isodesmosine as biomarker in alpha-1-antritrypsin deficiency-related COPD.

Fregonese L, Ferrari F, Fumagalli M, Luisetti M, Stolk J, Iadarola P.

COPD. 2011 Oct;8(5):329-33. doi: 10.3109/15412555.2011.589871. Epub 2011 Jul 27.

PMID:
21793711
12.

Determination of free desmosine in human plasma and its application in two experimental medicine studies.

Lamerz J, Friedlein A, Soder N, Cutler P, Döbeli H.

Anal Biochem. 2013 May 15;436(2):127-36. doi: 10.1016/j.ab.2013.01.012. Epub 2013 Feb 8.

PMID:
23399390
13.

Stable deuterium internal standard for the isotope-dilution LC-MS/MS analysis of elastin degradation.

Ma S, Turino GM, Hayashi T, Yanuma H, Usuki T, Lin YY.

Anal Biochem. 2013 Sep 15;440(2):158-65. doi: 10.1016/j.ab.2013.05.014. Epub 2013 May 30.

PMID:
23727558
14.

Micellar electrokinetic chromatography with laser induced detection and liquid chromatography tandem mass-spectrometry-based desmosine assays in urine of patients with Chronic Obstructive Pulmonary Disease: a comparative analysis.

Ferrari F, Fumagalli M, Piccinini P, Stolk J, Luisetti M, Viglio S, Tinelli C, Iadarola P.

J Chromatogr A. 2012 Nov 30;1266:103-9. doi: 10.1016/j.chroma.2012.10.014. Epub 2012 Oct 13.

PMID:
23116803
15.

Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters.

Calikoglu M, Sahin G, Unlu A, Ozturk C, Tamer L, Ercan B, Kanik A, Atik U.

Respiration. 2004 Jan-Feb;71(1):45-50.

PMID:
14872110
16.

Matrix elastin: a promising biomarker for chronic obstructive pulmonary disease.

Turino GM, Ma S, Lin YY, Cantor JO, Luisetti M.

Am J Respir Crit Care Med. 2011 Sep 15;184(6):637-41. doi: 10.1164/rccm.201103-0450PP. Review.

PMID:
21757624
17.

Measurements of desmosine and isodesmosine by mass spectrometry in COPD.

Ma S, Lin YY, Turino GM.

Chest. 2007 May;131(5):1363-71.

PMID:
17494786
18.

High-sensitivity nanoLC-MS/MS analysis of urinary desmosine and isodesmosine.

Boutin M, Berthelette C, Gervais FG, Scholand MB, Hoidal J, Leppert MF, Bateman KP, Thibault P.

Anal Chem. 2009 Mar 1;81(5):1881-7. doi: 10.1021/ac801745d.

19.

Development of a robust LC-MS/MS method for determination of desmosine and isodesmosine in human urine.

Shiraishi K, Matsuzaki K, Matsumoto A, Hashimoto Y, Iba K.

J Oleo Sci. 2010;59(8):431-9.

20.

[Desmosine plasma levels and exacerbation risk assessment of chronic obstructive pulmonary disease].

Yang Y, Guo Y, Zhang H, Sun T.

Zhonghua Yi Xue Za Zhi. 2015 Mar 3;95(8):577-80. Chinese.

PMID:
25917031

Supplemental Content

Support Center